Royal Bank of Canada
AMED

Royal Bank of Canada’s Amedisys AMED Stock Holding History

Royal Bank of Canada’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187,627
Closed -$18.5M – 7092
2025
Q2 		$18.5M Buy
187,627
+35,670
+23% +$3.37M ﹤0.01% 1591
2025
Q1 		$14.1M Buy
151,957
+150,007
+7,693% +$13.8M ﹤0.01% 1545
2024
Q4 		$177K Sell
1,950
-1,125
-37% -$103K ﹤0.01% 4911
2024
Q3 		$297K Sell
3,075
-3,942
-56% -$385K ﹤0.01% 4514
2024
Q2 		$645K Sell
7,017
-18,656
-73% -$1.73M ﹤0.01% 3807
2024
Q1 		$2.37M Sell
25,673
-47,682
-65% -$4.47M ﹤0.01% 2787
2023
Q4 		$6.97M Buy
73,355
+68,246
+1,336% +$6.37M ﹤0.01% 1999
2023
Q3 		$477K Sell
5,109
-38,893
-88% -$3.59M ﹤0.01% 4073
2023
Q2 		$4.02M Buy
44,002
+5,374
+14% +$441K ﹤0.01% 2263
2023
Q1 		$2.84M Buy
38,628
+1,392
+4% +$120K ﹤0.01% 2533
2022
Q4 		$3.11M Sell
37,236
-3,713
-9% -$335K ﹤0.01% 2526
2022
Q3 		$3.96M Buy
40,949
+301
+0.7% +$35.9K ﹤0.01% 2264
2022
Q2 		$4.27M Sell
40,648
-6,894
-15% -$881K ﹤0.01% 2231
2022
Q1 		$8.19M Buy
47,542
+2,116
+5% +$316K ﹤0.01% 1867
2021
Q4 		$7.35M Buy
45,426
+13,376
+42% +$2.15M ﹤0.01% 2109
2021
Q3 		$4.78M Sell
32,050
-7,023
-18% -$1.46M ﹤0.01% 2327
2021
Q2 		$9.57M Buy
39,073
+2,737
+8% +$718K ﹤0.01% 1837
2021
Q1 		$9.62M Buy
36,336
+2,169
+6% +$612K ﹤0.01% 1788
2020
Q4 		$10M Buy
34,167
+13,885
+68% +$3.56M ﹤0.01% 1707
2020
Q3 		$4.79M Sell
20,282
-605
-3% -$138K ﹤0.01% 2036
2020
Q2 		$4.15M Sell
20,887
-20,226
-49% -$3.77M ﹤0.01% 2074
2020
Q1 		$7.55M Buy
41,113
+12,313
+43% +$2.19M ﹤0.01% 1534
2019
Q4 		$4.81M Sell
28,800
-14,536
-34% -$2.16M ﹤0.01% 2177
2019
Q3 		$5.68M Sell
43,336
-25,711
-37% -$3.35M ﹤0.01% 1987
2019
Q2 		$8.38M Buy
69,047
+39,949
+137% +$4.74M ﹤0.01% 1690
2019
Q1 		$3.59M Buy
29,098
+6,988
+32% +$877K ﹤0.01% 2257
2018
Q4 		$2.59M Buy
22,110
+13,562
+159% +$1.6M ﹤0.01% 2464
2018
Q3 		$1.07M Sell
8,548
-3,672
-30% -$405K ﹤0.01% 3311
2018
Q2 		$1.04M Sell
12,220
-44,350
-78% -$3.26M ﹤0.01% 3192
2018
Q1 		$3.41M Buy
56,570
+15,307
+37% +$872K ﹤0.01% 2277
2017
Q4 		$2.17M Buy
41,263
+15,382
+59% +$811K ﹤0.01% 2659
2017
Q3 		$1.45M Buy
25,881
+19,644
+315% +$1.04M ﹤0.01% 2921
2017
Q2 		$392K Buy
6,237
+5,798
+1,321% +$338K ﹤0.01% 3851
2017
Q1 		$23K Sell
439
-515
-54% -$24.6K ﹤0.01% 5550
2016
Q4 		$41K Buy
954
+699
+274% +$29.7K ﹤0.01% 5369
2016
Q3 		$11K Sell
255
-5,009
-95% -$250K ﹤0.01% 5748
2016
Q2 		$266K Buy
5,264
+5,214
+10,428% +$263K ﹤0.01% 4202
2016
Q1 		$2K Sell
50
-1,761
-97% -$67.9K ﹤0.01% 6112
2015
Q4 		$71K Buy
1,811
+684
+61% +$27.4K ﹤0.01% 5125
2015
Q3 		$43K Buy
1,127
+38
+3% +$1.6K ﹤0.01% 5205
2015
Q2 		$43K Sell
1,089
-1,536
-59% -$47.9K ﹤0.01% 5299
2015
Q1 		$70K Sell
2,625
-10,392
-80% -$293K ﹤0.01% 4802
2014
Q4 		$382K Sell
13,017
-6,083
-32% -$150K ﹤0.01% 3832
2014
Q3 		$386K Sell
19,100
-15,380
-45% -$297K ﹤0.01% 3700
2014
Q2 		$577K Buy
34,480
+23,950
+227% +$339K ﹤0.01% 3286
2014
Q1 		$157K Buy
10,530
+3,378
+47% +$52K ﹤0.01% 4280
2013
Q4 		$105K Sell
7,152
-2,313
-24% -$37.2K ﹤0.01% 4544
2013
Q3 		$163K Sell
9,465
-14,207
-60% -$211K ﹤0.01% 4205
2013
Q2 		$275K Buy
+23,672
New +$271K ﹤0.01% 3637

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's AMED Position: Q3 2025 in Review

Royal Bank of Canada sold out of Amedisys (AMED) in Q3 2025, closing a stake of 187,627 shares — an estimated $18.5M sold.

Royal Bank of Canada first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $18.5M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Royal Bank of Canada reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 187,627 Amedisys shares in Q3 2025, an estimated $18.5M.
  • Royal Bank of Canada first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Royal Bank of Canada's Amedisys position peaked at $18.5M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.